Nigerian scientist, Dr. Louis Obyo Finds That Verona Amygdalina (Bitter Leaf) Cures Diabetes
A Nigerian scientist, Dr. Louis Obyo Obyo Nelson, has finally found a cure for the dreaded diabetes disease which afflicts over 123 million sufferers all over the world.
The Minister of State for Health, Dr Aliyu Idi Hong, yesterday described as “epoch and historical” the production of Antidiabetic Phytophar-maceutical by Nelson in collaboration with the Nigerian Pharmaceutical Research and Development.
Diabetes is a potentially life- threatening condition in mammals brought about by an inability of the mammals to produce insulin. Insulin, a polypeptide hormone produced in the pancreas of the mammal, controls the amounts of glucose present in the blood by stimulating the uptake of glucose by the muscle and adipose tissue.
THISDAY had exclusively reported on May 23, 2003 that Nelson had been granted a United States patent entitled “Medicament for the Treatment of Diabetes”, a feat that raised hopes for millions of sufferers of the disease worldwide. It also exclusively reported on June 5, 2003 a confirmation from the US Patent Office that indeed a patent had been made out to the Nigerian scientist.
Hong said yesterday at the signing of an agreement between Nelson and GDPAU, New Brunswick, New Jersey, USA, for the commercialisation of an Antidiabetic Phaytopharmaceutical in Abuja that the drug would contribute to the quality of health care all over the world and boost the economy of the country.
The drug, which was said to have been administered on many diabetic victims, has been found to be very safe and highly effective. It was also said to have corrected erective dysfunctions noticed in those victims.
……………………………………………………………
Nelson recorded a breakthrough in his research for a drug that could cure diabetes when the US government issued him with a patent (No. 6,531,461) for his medication, which can effectively treat Type I and Type II diabetes.
………………
Nelson’s drug had been subjected to two clinical trials the last being at the University of Jos Teaching Hospital (UJTH).
At the first clinical trial, the initial extract derived from Vernonia amygdalina was orally administered to 26 patients all of whom had been previously diagnosed as suffering from insulin deficiency. For control, a group of five were used, who maintained diet discipline throughout the trial. The initial extract was dosed to the patients three times daily in 100mg aliquots for six months.
The blood glucose levels of all 31 subjects were closely monitored. It was revealed that the 26 patients receiving the initial extract no longer required maintaining diet discipline after the first month and examination showed remission of the disease after three months.
Fifteen patients were said to have continued receiving medication for the remaining three months of the trial.
All those who volunteered for the experiment appeared to have recovered from the disease and have returned to their normal life prior to the diagnosis of the disease.
Nelson, 61, who holds a doctorate degree in Molecular and Computational Chemistry from the University of Ibadan, hails from Nsit Ubium Local Government Area of Akwa Ibom State.
He served as Permanent Secretary in the Ministry of Science and Technology in 2001, worked with the Raw Materials Research and Development Council.
More @ http://www.thisdayonline.com/nview.php?id=134751
where do you get this meds.